CLRO

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 2.31 M1.92 M0-4.23 M00 -4.23 M Gross profit 121 K-231 K-27 K-174 K-70 K-70 K -341 K Operating expenses 2.97 M4.33 M827 K1.35 M780 K849 K 3.81 M Selling/general/admin expenses 2.28 M2.97 M827 K-1.12 M780 K849 K 1.34 M Research & development 691 K1.36 M0—00 — Operating income -2.85 M-4.56 M-854 K-1.52 M-850 K-919 K -4.15 M Non-Operating Income, Total 12 K3 0004 000-136 K00 -132 K Interest expense, net of interest capitalized 08 00020 K—00 — Non-Operating Income, excl. Interest Expenses 0-8 000-20 K000 -20 K Unusual income/expense 12 K3 0004 000-136 K00 -132 K Pretax income -2.83 M-4.56 M-870 K-1.66 M-850 K-919 K -4.3 M Equity in earnings —————— — Taxes 08 0001 00074 K00 75 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -4.85 M-4.57 M-871 K-1.73 M-850 K-919 K -4.37 M Discontinued operations 2.02 M-2.98 M-12.87 M-3.21 M363 K5 000 -15.71 M Net income -2.83 M-4.57 M-13.74 M-4.94 M-487 K-914 K -20.08 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -2.83 M-4.57 M-13.74 M-4.94 M-487 K-914 K -20.08 M Basic earnings per share (Basic EPS) -1.65-2.64-7.92-2.5-0.21-0.34 -10.97 Diluted earnings per share (Diluted EPS) -1.65-2.64-7.92-2.5-0.18-0.34 -10.94 Average basic shares outstanding 1.65 M1.73 M1.73 M1.77 M2.38 M2.68 M — Diluted shares outstanding 1.65 M1.73 M1.73 M1.77 M2.75 M2.68 M — EBITDA -2.8 M-4.51 M———— — EBIT -2.85 M-4.56 M-854 K3.86 M-850 K-919 K 1.24 M Cost of revenue 2.19 M2.15 M27 K-4.04 M70 K70 K -3.87 M Other cost of goods sold 272 K48 K0——— — Depreciation & amortization (cash flow) 50 K51 K———— —